ARCHIVES

NCI’s Goal To Increase Minority Participation In Trials, Sondik Says

This article is from The Cancer Letter archive.

Vol. 21 No. 18 | May 5, 1995

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

November 7, 2008

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011

Tip O’Neill Testifies As Cancer Survivor At Hearing Called To Renew Commitment To ‘War On Cancer’

April 26, 1991

In Brief: Hazleton Acquires Prime Labs, Primate Importer; Cullen UCLA Deputy Director

July 30, 1976

Vanderbilt-Ingram Wins NCI SPORE Grant

April 19, 2002

Remarks on HPV Vaccines, SPORE Funds Create Controversy for NCI’s John Niederhuber.

April 14, 2006